|
市場調査レポート
商品コード
1609693
日本のオリゴヌクレオチド合成市場レポート：製品、用途、最終用途、地域別、2025年～2033年Japan Oligonucleotide Synthesis Market Report by Product, Application (PCR Primers, PCR Assays and Panels, Sequencing, DNA Microarrays, Fluorescence In-Situ Hybridization, Antisense Oligonucleotides, and Others), End Use, and Region 2025-2033 |
||||||
カスタマイズ可能
|
|||||||
| 日本のオリゴヌクレオチド合成市場レポート：製品、用途、最終用途、地域別、2025年～2033年 |
|
出版日: 2024年12月05日
発行: IMARC
ページ情報: 英文 122 Pages
納期: 5～7営業日
|
- 全表示
- 概要
- 目次
日本のオリゴヌクレオチド合成市場の市場規模は2024年に2億490万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに6億300万米ドルに達し、2025年から2033年の間に11.42％の成長率（CAGR）を示すと予測しています。バイオインフォマティクスとデータサイエンスの著しい成長と相まって、新規治療戦略の広範な採用が主に市場成長を牽引しています。
本レポートで扱う主な質問
- 日本のオリゴヌクレオチド合成市場はこれまでどのように推移し、今後どのように推移するのか？
- COVID-19が日本のオリゴヌクレオチド合成市場に与えた影響は？
- 日本のオリゴヌクレオチド合成市場の製品別構成比は？
- 日本のオリゴヌクレオチド合成市場の用途別内訳は？
- 日本のオリゴヌクレオチド合成市場の最終用途別の内訳は？
- 日本のオリゴヌクレオチド合成市場のバリューチェーンにはどのような段階がありますか？
- 日本のオリゴヌクレオチド合成における主な促進要因と課題は？
- 日本のオリゴヌクレオチド合成市場の構造と主要プレーヤーは？
- 日本のオリゴヌクレオチド合成市場における競合の程度は？
目次
第1章 序文
第2章 調査範囲と調査手法
- 調査の目的
- ステークホルダー
- データソース
- 市場推定
- 調査手法
第3章 エグゼクティブサマリー
第4章 日本のオリゴヌクレオチド合成市場：イントロダクション
- 概要
- 市場力学
- 業界動向
- 競合情報
第5章 日本のオリゴヌクレオチド合成市場情勢
- 過去および現在の市場動向（2019年～2024年）
- 市場予測（2025-2033）
第6章 日本のオリゴヌクレオチド合成市場：製品別の内訳
- 合成オリゴヌクレオチド製品
- 試薬
- 装置
- サービス
第7章 日本のオリゴヌクレオチド合成市場：用途別の内訳
- PCRプライマー
- PCRアッセイとパネル
- シーケンシング
- DNAマイクロアレイ
- 蛍光in-situハイブリダイゼーション（FISH）
- アンチセンスオリゴヌクレオチド
- その他
第8章 日本のオリゴヌクレオチド合成市場：最終用途別の内訳
- 製薬・バイオテクノロジー企業
- 病院および診断ラボ
- 学術研究機関
第9章 日本のオリゴヌクレオチド合成市場：競合情勢
- 概要
- 市場構造
- 市場プレーヤーのポジショニング
- 主要成功戦略
- 競合ダッシュボード
- 企業評価象限
第10章 主要企業のプロファイル
第11章 日本のオリゴヌクレオチド合成市場：業界分析
- 促進要因・抑制要因・機会
- ポーターのファイブフォース分析
- バリューチェーン分析
第12章 付録
Japan oligonucleotide synthesis market size reached USD 204.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 603.0 Million by 2033, exhibiting a growth rate (CAGR) of 11.42% during 2025-2033. The widespread adoption of novel therapeutic strategies, coupled with significant growth of bioinformatics and data science, is primarily driving the market growth.
Oligonucleotide synthesis is the procedure for constructing short DNA or RNA molecules, known as oligonucleotides, with a specific sequence. These sequences can vary in length from just a few bases to approximately 200 nucleotides. This process is typically carried out through chemical synthesis in a controlled laboratory setting, often utilizing solid-phase phosphoramidite chemistry. In this approach, nucleotides are sequentially added to a growing chain, with each addition involving a series of chemical reactions. This technology allows scientists to create tailor-made oligonucleotides for a range of applications, including gene synthesis, polymerase chain reaction (PCR), gene editing tools like CRISPR-Cas9, and molecular diagnostic tests. Advances in oligonucleotide synthesis have greatly accelerated research in genomics and molecular biology, playing a pivotal role in numerous breakthroughs in medical and biological research.
Japan Oligonucleotide Synthesis Market Trends:
The Japanese market for oligonucleotides is primarily propelled by the increasing incidence of genetic diseases within the population. This necessitates the exploration of novel therapeutic approaches, with a significant role being played by oligonucleotide-based therapies. For example, therapies utilizing small interfering RNAs (siRNAs) and antisense oligonucleotides are being researched and applied in the treatment of genetic disorders like Duchenne muscular dystrophy and spinal muscular atrophy. Consequently, the growing prevalence of genetic diseases is driving demand not only in Japan but also on a wide scale. Furthermore, the expansion of bioinformatics and data science is directly impacting the oligonucleotide synthesis sector. The increasing capacity to analyze extensive genomic datasets is positively influencing the market by generating greater demand for the synthesis of innovative oligonucleotides. Additionally, oligonucleotides, particularly antisense oligonucleotides, have proven effective in epigenetic research and therapy, facilitating gene expression modulation and contributing to a favorable market outlook. Moreover, collaborations and partnerships between pharmaceutical companies, biotechnology firms, and research institutions have become crucial drivers in advancing the development and commercialization of oligonucleotide therapies for genetic diseases. These collaborative efforts are expected to fuel the regional market over the forecasted period.
Japan Oligonucleotide Synthesis Market Segmentation:
Product Insights:
- Synthesized Oligonucleotide Products
- Reagents
- Equipment
- Services
Application Insights:
- PCR Primers
- PCR Assays and Panels
- Sequencing
- DNA Microarrays
- Fluorescence In-Situ Hybridization (FISH)
- Antisense Oligonucleotides
- Others
End Use Insights:
- Pharmaceutical and Biotechnology Companies
- Hospital and Diagnostic Laboratories
- Academic Research Institutes
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Questions Answered in This Report:
- How has the Japan oligonucleotide synthesis market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Japan oligonucleotide synthesis market?
- What is the breakup of the Japan oligonucleotide synthesis market on the basis of product?
- What is the breakup of the Japan oligonucleotide synthesis market on the basis of application?
- What is the breakup of the Japan oligonucleotide synthesis market on the basis of end use?
- What are the various stages in the value chain of the Japan oligonucleotide synthesis market?
- What are the key driving factors and challenges in the Japan oligonucleotide synthesis?
- What is the structure of the Japan oligonucleotide synthesis market and who are the key players?
- What is the degree of competition in the Japan oligonucleotide synthesis market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Japan Oligonucleotide Synthesis Market - Introduction
- 4.1 Overview
- 4.2 Market Dynamics
- 4.3 Industry Trends
- 4.4 Competitive Intelligence
5 Japan Oligonucleotide Synthesis Market Landscape
- 5.1 Historical and Current Market Trends (2019-2024)
- 5.2 Market Forecast (2025-2033)
6 Japan Oligonucleotide Synthesis Market - Breakup by Product
- 6.1 Synthesized Oligonucleotide Products
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
- 6.2 Reagents
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
- 6.3 Equipment
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
- 6.4 Services
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)
7 Japan Oligonucleotide Synthesis Market - Breakup by Application
- 7.1 PCR Primers
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
- 7.2 PCR Assays and Panels
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
- 7.3 Sequencing
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
- 7.4 DNA Microarrays
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
- 7.5 Fluorescence In-Situ Hybridization (FISH)
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2019-2024)
- 7.5.3 Market Forecast (2025-2033)
- 7.6 Antisense Oligonucleotides
- 7.6.1 Overview
- 7.6.2 Historical and Current Market Trends (2019-2024)
- 7.6.3 Market Forecast (2025-2033)
- 7.7 Others
- 7.7.1 Historical and Current Market Trends (2019-2024)
- 7.7.2 Market Forecast (2025-2033)
8 Japan Oligonucleotide Synthesis Market - Breakup by End Use
- 8.1 Pharmaceutical and Biotechnology Companies
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
- 8.2 Hospital and Diagnostic Laboratories
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
- 8.3 Academic Research Institutes
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
9 Japan Oligonucleotide Synthesis Market - Competitive Landscape
- 9.1 Overview
- 9.2 Market Structure
- 9.3 Market Player Positioning
- 9.4 Top Winning Strategies
- 9.5 Competitive Dashboard
- 9.6 Company Evaluation Quadrant
10 Profiles of Key Players
- 10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
- 10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
- 10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
- 10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
- 10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events
11 Japan Oligonucleotide Synthesis Market - Industry Analysis
- 11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
- 11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
- 11.3 Value Chain Analysis
